企業プロフィール
Personalis 株価・ニュース・カタリスト
- ティッカー:
- PSNL
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
13.89 USD (-1.07%)
終値
最終更新: 2026年8月17日
1.17B USD
時価総額
株価変動の要因
As of Aug 17, 2026, PSNL closed down 1.07% at $13.89. No new same-company headline was identified in the current news window.
企業概要
Precision-Oncology Genomics
Personalis develops genomic tests for cancer detection, monitoring and therapy development. Its platform uses highly sensitive sequencing and tumor-informed analysis to identify minimal residual disease.
NeXT Personal
NeXT Personal is a personalized circulating-tumor-DNA test designed to detect and track cancer recurrence from blood. Clinical use includes surveillance in lung and breast cancer. Personalis serves physicians through reimbursed clinical testing and pharmaceutical companies through translational research, clinical-trial and biomarker services.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。